BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,802,416 | -52.4% | 71,819 | -52.7% | 0.02% | -60.0% |
| Q2 2023 | $16,400,395 | +184.6% | 151,954 | +228.5% | 0.05% | +117.4% |
| Q1 2023 | $5,761,985 | +49.3% | 46,255 | +80.0% | 0.02% | +53.3% |
| Q4 2022 | $3,860,053 | -14.0% | 25,696 | -14.6% | 0.02% | -40.0% |
| Q2 2022 | $4,489,000 | -8.8% | 30,104 | +4.3% | 0.02% | +19.0% |
| Q1 2022 | $4,920,000 | +101.0% | 28,851 | +203.9% | 0.02% | +250.0% |
| Q4 2021 | $2,448,000 | -35.9% | 9,495 | -32.1% | 0.01% | -45.5% |
| Q3 2021 | $3,820,000 | +94.4% | 13,993 | +59.4% | 0.01% | +57.1% |
| Q2 2021 | $1,965,000 | +13.5% | 8,779 | -58.7% | 0.01% | -46.2% |
| Q4 2020 | $1,731,000 | +185.6% | 21,233 | +142.7% | 0.01% | +62.5% |
| Q3 2020 | $606,000 | +74.1% | 8,749 | +68.0% | 0.01% | +33.3% |
| Q2 2020 | $348,000 | – | 5,207 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |